Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: A case report

Digestive Diseases and Sciences

Volumn 50, Issue 11, 2005, Pages 2059-2062

  Agrawal, Amit ^a   Tutuian, Radu ^a   Hila, Amine ^a   Castell, Donald O ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Chest pain; Esophageal motility; PD 5 inhibitors

Indexed keywords

ANTACID AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRATE; PHOSPHODIESTERASE V INHIBITOR; PROTON PUMP INHIBITOR; SILDENAFIL; TADALAFIL; TRICYCLIC ANTIDEPRESSANT AGENT; VARDENAFIL;

ADULT; ARTICLE; CASE REPORT; DYSPHAGIA; ESOPHAGUS FUNCTION DISORDER; HEARTBURN; HUMAN; MALE; MUSCLE CONTRACTILITY; PRIORITY JOURNAL; THORAX PAIN;

ADULT; CARBOLINES; ESOPHAGEAL MOTILITY DISORDERS; HUMANS; IMIDAZOLES; MALE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; SULFONES; TRIAZINES;

EID: 27144503030     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-3007-9     Document Type: Article

References (16)

1. Tutuian R, Castell DO: Combined multichannel intraluminal impedance and manometry clarifies the function defect in patients with distal esophageal spasm. Gastroenterology 126(Suppl 2):A638, 2004 (abstract)
2. Allen ML, DiMarino AJ Jr: Manometric diagnosis of diffuse esophageal spasm. Dig Dis Sci 41:1346-1349, 1996
3. Katz PO, Dalton CB, Richter JE, et al.: Esophageal testing in patients with noncardiac chest pain or dysphagia: results of three years' experience with 1161 patients. Ann Intern Med 106:593-597, 1987
4. Cohen S: Esophageal motility disorders and their response to calcium channel antagonists. The sphinx revisited. Gastroenterology 93:201-203, 1987
5. Kahrilas PJ: Esophageal motility disorders: current concepts of pathogenesis and treatment. Can J Gastroenerol 14:221-231, 2000
6. Richter JE: Oesophageal motility disorders. Lancet 358:823-828, 2001
7. Spechler SJ, Castell DO: Classification of oesophageal motility abnormalities. Gut 49:145-151, 2001
8. Clouse RE, Staiano A: Manometric patterns using esophageal body and lower sphincter characteristics. Findings in 103 patients. Dig Dis Sci 37:289-296, 1992
9. Richter JE, Bradley LA, Castell DO: Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy. Ann Intern Med 110:66-78, 1989
10. Richter JE, Castell DO: Diffuse esophageal spasm: a reappraisal. Ann Intern Med 100:242-245, 1984
11. Murray JA, Ledlow A, Launspach J, Evans D, Loveday M, Conklin JL: The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 109:1241-1248, 1995
12. Konturek JW, Gillessen A, Domschke W: Diffuse esophageal spasm: a malfunction that involves nitric oxide? Scand J Gastroenterol 30:1041-1045, 1995
13. Eherer AJ, Schwetz I, Hammer HF, Petnehazy T, Scheidl SJ, Weber K, Krejs GJ: Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 50:758-764, 2002
14. Simren M, Silny J, Holloway R, Tack J, Janssens J, Sifrim D: Relevance of ineffective oesophageal motility during oesophageal acid clearance. Gut 52:784-790, 2003
15. Nathan HP, McCullough AR, Giuliano F, Toler S, Wohlhuter C, Shpilsky A: Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Abstract presented at American Urological Association meeting, 2003
16. Montorsi F, Nathan HP, McCullough A, Brock GB, Broderick G, Ahuja S, Whitaker S, Hoover A, Novack D, Murphy A, Varanese L: Postoperative nightly administration of tadalfil significantly improves the return of normal spontaneous erectile dysfunction after bilateral nerve-sparing radical prostatectomy. J Urol 2:1036-1041, 2004